The value of vaccine booster doses to mitigate the global impact of the Omicron SARS-CoV-2 variant (2022)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2022.01.17.22269222
Publication URI: http://dx.doi.org/10.1101/2022.01.17.22269222
Type: Preprint